TerminatedNot Applicable

Round Spermatid Injection Protocol

Stopped: low enrollment

United States3 participantsStarted 2019-08-16

Plain-language summary

To evaluate embryology outcomes after application of a technique known as round spermatid injection (ROSI) into donor oocytes in a high-volume clinical infertility practice.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. A diagnosis of azoospermia after semen analysis.
✓. Indication to proceed with testicular sperm extraction (TESE or microTESE) based on a urologic evaluation.
✓. Presence of round spermatids from testicular sperm extraction (TESE or microTESE), irrespective of the presence or absence of mature spermatozoa.

Exclusion criteria

✕. Under 18 years old
✕. All patients who do not voluntarily give their written consent for participation.
✕. Men who do not wish to use their gametes (round spermatids) for fertilization of donor oocytes for research purposes.

What they're measuring

Euploid blastulation rate

Timeframe: 1-2 weeks

Trial details

NCT IDNCT04053309

SponsorReproductive Medicine Associates of New Jersey

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-01-08

View on ClinicalTrials.gov More Male Infertility Due to Azoospermia trials